HomeOTLK • NASDAQ
add
Outlook Therapeutics Inc
Previous close
$0.43
Day range
$0.41 - $0.45
Year range
$0.38 - $3.39
Market cap
34.32M USD
Avg Volume
2.73M
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
In the news
Financials
Income Statement
Revenue
Net income
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Revenue | -1.21M | — |
Operating expense | 8.61M | -27.91% |
Net income | -23.06M | -232.69% |
Net profit margin | 1.91K | — |
Earnings per share | -0.22 | 75.28% |
EBITDA | -13.45M | 37.65% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Cash and short-term investments | 8.68M | 52.17% |
Total assets | 18.24M | 7.25% |
Total liabilities | 56.79M | -15.62% |
Total equity | -38.55M | — |
Shares outstanding | 83.07M | — |
Price to book | -0.72 | — |
Return on assets | -183.09% | — |
Return on capital | 1,847.46% | — |
Cash Flow
Net change in cash
| (USD) | Dec 2025info | Y/Y change |
|---|---|---|
Net income | -23.06M | -232.69% |
Cash from operations | -14.94M | -36.21% |
Cash from investing | — | — |
Cash from financing | 15.53M | 791.51% |
Net change in cash | 594.34K | 106.44% |
Free cash flow | -10.17M | -250.62% |
About
Founded
2010
Website
Employees
17
